Vaccine News and Research

Latest Vaccine News and Research

Constructing SARS-CoV-2 virus-like particles in tobacco plants for vaccine development

In a study published in the latest issue of the Scientific Reports, a team of researchers constructed virus-like particles (VLPs) composed of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M), envelope (E), and nucleocapsid (N) proteins in tobacco plant using Agrobacterium-mediated delivery.

24 Jan 2022

Lower risk of vaccine-breakthrough infections for mRNA-1273 recipients

Recently, a team of researchers examined breakthrough infections, hospitalizations, and mortality rates in double-dose messenger RNA (mRNA) vaccine recipients in a research letter published in the Journal of American Medical Association (JAMA).

24 Jan 2022

COVID-19 testing measures simplified for travelers arriving in the UK from 11 February

All testing measures for eligible fully vaccinated travelers arriving in the UK will be removed from 4am on 11 February, as the government goes one step further to reopen the travel sector.

24 Jan 2022

Impact of SARS-CoV-2 booster vaccination on Delta variant resurgence in Israel

In a new study, researchers constructed a discrete-time age-of-infection age-stratified transmission model to accurately determine the individual to population-level data on SARS-CoV-2 Delta surge dynamics in Israel

24 Jan 2022

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

A new study assessed the dynamics of IgG titers over 18 months in patients who had recovered from COVID-19 infections during March 2020.

24 Jan 2022

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Researchers have investigated the pathology and inflammatory response to the Delta variant in mice.

24 Jan 2022

NHS England grants £8 million to support in-school vaccination program

New multi-million-pound funding from NHS England will enable all schools to fully support the in-school vaccination program, and air cleaning units will be provided in all classrooms and teaching spaces that need them, the Education Secretary has announced today, Monday 24 January.

24 Jan 2022

Vaccine wars ignite in California as lawmakers seek stronger laws

California is poised to become the front line of America's vaccination wars. State lawmakers are drafting the toughest covid-19 vaccine legislation in the country, backed by a new pro-vaccine lobbying force promising to counter anti-vaccine activists who have threatened government officials and shut down public meetings across the state.

24 Jan 2022

Study finds stable T-Cell response against Omicron after mRNA booster vaccination

A new study measured T cell activity in vaccinated individuals and found a third vaccine provided substantial T-cell immunity against the Omicron variant of SARS-CoV-2.

24 Jan 2022

People with depression may be more receptive to COVID-19 vaccine related misinformation

A general bias toward negativity - or the tendency to focus on negative rather than positive information - may exacerbate the spread of misinformation. Because depression may contribute to such negativity bias, a team led by investigators at Massachusetts General Hospital (MGH) examined whether people who experience depressive symptoms may be more receptive to misinformation related to COVID-19 vaccines.

24 Jan 2022

Third dose of mRNA vaccine found to be effective in protecting against Omicron-related ED visits

A nationwide study from the Centers for Disease Control and Prevention (CDC) has found that mRNA booster shots (either Pfizer or Moderna) are 82 percent effective in protecting against COVID-19 Omicron variant-associated emergency department (ED) visits and 90 percent effective in protecting against COVID-19 Omicron variant-related hospitalizations.

24 Jan 2022

Researchers are in the race to beat Omicron

David Veesler and his lab members aren't getting much sleep these days. In the final weeks of 2021, he and his team worked around the clock to post four coronavirus papers on the preprint server bioRxiv.

24 Jan 2022

Free cervical cancer screening and preventive treatment can benefit women in low-income communities

When 29-year-old Nyemma Wickham, arrived for a free pap test at the Family Health Centers at NYU Langone in Brooklyn earlier this month, she expected another routine visit.

24 Jan 2022

Study offers a cost-benefit analysis of lockdowns implemented due to the COVID-19 pandemic

The U.S. pandemic lockdown in 2020 caused a $2.3 trillion economic downturn and split the nation politically, and now some European nations are locking down again as Omicron surges through the global population.

24 Jan 2022

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

A recent study published in the journal Science brings a detailed chemical and molecular perspective on the improved evasion of antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the retention of strong interactions with the receptor as two principal factors underneath the notorious transmissibility of the SARS-CoV-2 Omicron variant.

23 Jan 2022

Nirmatrelvir, Molnupiravir, and Remdesivir hold-up against SARS-CoV-2 Omicron variant in vitro

In a recent study posted to the bioRxiv* preprint server, researchers test three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals authorized for emergency use by the United States Food and Drug Administration (FDA) for their in vitro potency against several SARS-CoV-2 variants, including the currently dominant Omicron train.

23 Jan 2022

Vaccine News and Research

Latest Vaccine News and Research

Constructing SARS-CoV-2 virus-like particles in tobacco plants for vaccine development

Lower risk of vaccine-breakthrough infections for mRNA-1273 recipients

COVID-19 testing measures simplified for travelers arriving in the UK from 11 February

Impact of SARS-CoV-2 booster vaccination on Delta variant resurgence in Israel

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

NHS England grants £8 million to support in-school vaccination program

Vaccine wars ignite in California as lawmakers seek stronger laws

Study finds stable T-Cell response against Omicron after mRNA booster vaccination

People with depression may be more receptive to COVID-19 vaccine related misinformation

Third dose of mRNA vaccine found to be effective in protecting against Omicron-related ED visits

Researchers are in the race to beat Omicron

Free cervical cancer screening and preventive treatment can benefit women in low-income communities

Study offers a cost-benefit analysis of lockdowns implemented due to the COVID-19 pandemic

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

Nirmatrelvir, Molnupiravir, and Remdesivir hold-up against SARS-CoV-2 Omicron variant in vitro

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Robust BNT162b2 vaccine-induced B and T-cell immunity against early SARS-CoV-2 variants

CoronaVac provides herd immunity in region of the Colombian Amazon

Paxlovid provides a glimpse into the future against SARS-CoV-2

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in